ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PPH VanEck Pharmaceuticals ETF

88.58
0.64 (0.73%)
22 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2012
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.38M
Operating Income 0
Pre Tax Income 0
Net Income 2.12M
Preferred Dividends 0
Basic Earnings Per Share (EPS) 0
EBIT 2.12M
EBITDA 2.07M
Year End 30 September 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.91M7.19M5.77M4.3M4.21M5.62M8.92M10.39M
Operating Income 00000000
Pre Tax Income 00000000
Net Income 5.89M6.05M4.61M-25.57M28.27M41.02M-57.82M92.32M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 1.4581.2251.075-10.2777.4629.349-7.42417.134
EBIT 5.89M6.05M4.61M3.58M3.5M4.72M7.41M8.74M
EBITDA 5.73M6.05M4.61M3.58M3.5M4.72M7.41M8.74M

Your Recent History

Delayed Upgrade Clock